Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark C Manning

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Current Pharmaceutical Biotechnology|December 5, 2002
The stability factor: importance in formulation developmentRajesh Krishnamurthy, Mark C Manning
Pharmaceutical Biotechnology|May 4, 2002
High throughput formulation: strategies for rapid development of stable protein productsRajiv Nayar, Mark C Manning
Pharmaceutical Biotechnology|May 4, 2002
Effects of conformation on the chemical stability of pharmaceutically relevant polypeptidesJeffrey D Meyer, Bert Ho, Mark C Manning
Current Pharmaceutical Biotechnology|August 8, 2002
Encapsulating DNA within biodegradable polymeric microparticlesCorinne S Lengsfeld, Mark C Manning, Theodore W Randolph
Journal of Pharmaceutical Sciences|January 6, 2004
Effects of potassium bromide disk formation on the infrared spectra of dried model proteinsJeffrey D Meyer, Mark C Manning, John F Carpenter
Current Protocols in Protein Science|April 23, 2008
Long-term storage of proteinsJohn F Carpenter, Mark C Manning, Theodore W Randolph
Advances in Protein Chemistry and Structural Biology|April 23, 2018
Rational Design of Liquid Formulations of ProteinsMark C Manning, Jun Liu, Tiansheng Li, et al.
Biochimica Et Biophysica Acta|August 5, 2003
The use of fluorescence resonance energy transfer to monitor dynamic changes of lipid-DNA interactions during lipoplex formationYe Zhang, William Garzon-Rodriguez, Mark C Manning, et al.
Current Pharmaceutical Biotechnology|October 14, 2014
Use of the amide II infrared band of proteins for secondary structure determination and comparability of higher order structureBrian M Murphy, Jennifer D'Antonio, Mark C Manning, et al.
Journal of Pharmaceutical Sciences|December 1, 2004
Heterogeneous nucleation-controlled particulate formation of recombinant human platelet-activating factor acetylhydrolase in pharmaceutical formulationEva Y Chi, Joachim Weickmann, John F Carpenter, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Current Pharmaceutical Biotechnology|December 5, 2002
The stability factor: importance in formulation developmentRajesh Krishnamurthy, Mark C Manning
Pharmaceutical Biotechnology|May 4, 2002
High throughput formulation: strategies for rapid development of stable protein productsRajiv Nayar, Mark C Manning
Pharmaceutical Biotechnology|May 4, 2002
Effects of conformation on the chemical stability of pharmaceutically relevant polypeptidesJeffrey D Meyer, Bert Ho, Mark C Manning
Current Pharmaceutical Biotechnology|August 8, 2002
Encapsulating DNA within biodegradable polymeric microparticlesCorinne S Lengsfeld, Mark C Manning, Theodore W Randolph
Journal of Pharmaceutical Sciences|January 6, 2004
Effects of potassium bromide disk formation on the infrared spectra of dried model proteinsJeffrey D Meyer, Mark C Manning, John F Carpenter
Current Protocols in Protein Science|April 23, 2008
Long-term storage of proteinsJohn F Carpenter, Mark C Manning, Theodore W Randolph
Advances in Protein Chemistry and Structural Biology|April 23, 2018
Rational Design of Liquid Formulations of ProteinsMark C Manning, Jun Liu, Tiansheng Li, et al.
Biochimica Et Biophysica Acta|August 5, 2003
The use of fluorescence resonance energy transfer to monitor dynamic changes of lipid-DNA interactions during lipoplex formationYe Zhang, William Garzon-Rodriguez, Mark C Manning, et al.
Current Pharmaceutical Biotechnology|October 14, 2014
Use of the amide II infrared band of proteins for secondary structure determination and comparability of higher order structureBrian M Murphy, Jennifer D'Antonio, Mark C Manning, et al.
Journal of Pharmaceutical Sciences|December 1, 2004
Heterogeneous nucleation-controlled particulate formation of recombinant human platelet-activating factor acetylhydrolase in pharmaceutical formulationEva Y Chi, Joachim Weickmann, John F Carpenter, et al.
Pageof 3